Journal for ImmunoTherapy of Cancer (Jun 2022)
Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells
- Reinhard Dummer,
- Marina Bacac,
- Pablo Umana,
- Mitchell P Levesque,
- Christine Trumpfheller,
- Mi He,
- Bhavesh Soni,
- Petra C Schwalie,
- Tamara Hüsser,
- Caroline Waltzinger,
- Duvini De Silva,
- Ylva Prinz,
- Laura Krümpelmann,
- Samuele Calabro,
- Ines Matos,
- Maries van den Broek,
- Stephan Gasser
Affiliations
- Reinhard Dummer
- Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
- Marina Bacac
- Roche Pharmaceutical Research and Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland
- Pablo Umana
- Roche Pharmaceutical Research and Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland
- Mitchell P Levesque
- Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
- Christine Trumpfheller
- 2Roche Glycart AG, Schlieren, Switzerland
- Mi He
- 1 Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland
- Bhavesh Soni
- 2 Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland
- Petra C Schwalie
- 2 Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland
- Tamara Hüsser
- 1 Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland
- Caroline Waltzinger
- 1 Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland
- Duvini De Silva
- 1 Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland
- Ylva Prinz
- 1 Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland
- Laura Krümpelmann
- 3 Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany
- Samuele Calabro
- 1 Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland
- Ines Matos
- 1 Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland
- Maries van den Broek
- 5 Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland
- Stephan Gasser
- 1 Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland
- DOI
- https://doi.org/10.1136/jitc-2021-004268
- Journal volume & issue
-
Vol. 10,
no. 6
Abstract
No abstracts available.